Literature DB >> 8025042

Uveitis and Lyme borreliosis.

J Breeveld1, H Kuiper, L Spanjaard, L Luyendijk, A Rothova.   

Abstract

In a retrospective study 56 consecutive patients with uveitis of unknown origin and 56 consecutive patients suffering from uveitis of established aetiology were investigated. The purpose of this study was to determine the frequency of positive serological tests for Lyme borreliosis among patients with uveitis and to relate laboratory data to clinical findings. The antibody titre for Borrelia burgdorferi was determined by two assays: the indirect immunofluorescence assay and the enzyme linked immunosorbent assay. A positive result according to one or both assays was found for eight patients with uveitis of unknown aetiology (14%) and three patients with uveitis of established cause (5%). On clinical examination, none of the patients fulfilled the CDC criteria for diagnosis of Lyme borreliosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8025042      PMCID: PMC504579          DOI: 10.1136/bjo.77.8.480

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

Review 1.  Lyme disease: neurologic and ophthalmic manifestations.

Authors:  J M Winterkorn
Journal:  Surv Ophthalmol       Date:  1990 Nov-Dec       Impact factor: 6.048

2.  Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme-linked immunosorbent assay.

Authors:  K Hansen; E Asbrink
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

3.  International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease.

Authors:  E Bloch-Michel; R B Nussenblatt
Journal:  Am J Ophthalmol       Date:  1987-02-15       Impact factor: 5.258

4.  Measurement of antibodies to the Borrelia burgdorferi flagellum improves serodiagnosis in Lyme disease.

Authors:  K Hansen; P Hindersson; N S Pedersen
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

5.  Antibody response in Lyme disease: evaluation of diagnostic tests.

Authors:  J E Craft; R L Grodzicki; A C Steere
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

6.  Serological diagnosis of erythema migrans disease and related disorders.

Authors:  B Wilske; G Schierz; V Preac-Mursic; K Weber; H W Pfister; K Einhäupl
Journal:  Infection       Date:  1984 Sep-Oct       Impact factor: 3.553

7.  Orbital myositis with Lyme disease.

Authors:  K B Seidenberg; M L Leib
Journal:  Am J Ophthalmol       Date:  1990-01-15       Impact factor: 5.258

8.  Detection of antibodies against Borrelia burgdorferi in patients with uveitis.

Authors:  E Isogai; H Isogai; S Kotake; K Yoshikawa; A Ichiishi; S Kosaka; N Sato; S Hayashi; K Oguma; S Ohno
Journal:  Am J Ophthalmol       Date:  1991-07-15       Impact factor: 5.258

9.  PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients.

Authors:  T L Keller; J J Halperin; M Whitman
Journal:  Neurology       Date:  1992-01       Impact factor: 9.910

10.  Cross-reactivity in serological tests for Lyme disease and other spirochetal infections.

Authors:  L A Magnarelli; J F Anderson; R C Johnson
Journal:  J Infect Dis       Date:  1987-07       Impact factor: 5.226

View more
  4 in total

1.  Ocular manifestations in children and adolescents with Lyme arthritis.

Authors:  H I Huppertz; D Münchmeier; W Lieb
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

Review 2.  Analysis of ocular fluids for local antibody production in uveitis.

Authors:  J H de Boer; L Luyendijk; A Rothova; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

Review 3.  Treatment of ocular inflammation in children.

Authors:  Sunil M Thadani; C Stephen Foster
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

4.  Seroprevalence against Rickettsia and Borrelia Species in Patients with Uveitis: A Prospective Survey.

Authors:  Kim B Madsen; Katarina Wallménius; Åke Fridman; Carl Påhlson; Kenneth Nilsson
Journal:  J Ophthalmol       Date:  2017-11-26       Impact factor: 1.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.